Nabriva Therapeutics (NBRVF) Q3 2022 Earnings

10NovExpected
Q4 2021
Q1 2022
Q2 2022
Q3 2022
-5
-3.4
-1.79
-0.19

Details

Expected EPS
-4.03
Actual EPS
-4.21
Surprise EPS
-0.18
Surprise Percent
+4.47%

Description

Nabriva Therapeutics (NBRVF) has reported earnings of -4.21 per share for Q3 2022.

0 Comments

Share your thoughts